IL206364A - Medicinal preparations containing at least one active protein component protected by digestive enzymes - Google Patents

Medicinal preparations containing at least one active protein component protected by digestive enzymes

Info

Publication number
IL206364A
IL206364A IL206364A IL20636410A IL206364A IL 206364 A IL206364 A IL 206364A IL 206364 A IL206364 A IL 206364A IL 20636410 A IL20636410 A IL 20636410A IL 206364 A IL206364 A IL 206364A
Authority
IL
Israel
Prior art keywords
active ingredient
pharmaceutical compositions
compositions containing
digestive enzymes
protein active
Prior art date
Application number
IL206364A
Other languages
English (en)
Hebrew (he)
Other versions
IL206364A0 (en
Original Assignee
Farid Bennis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farid Bennis filed Critical Farid Bennis
Publication of IL206364A0 publication Critical patent/IL206364A0/en
Publication of IL206364A publication Critical patent/IL206364A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IL206364A 2007-12-19 2010-06-14 Medicinal preparations containing at least one active protein component protected by digestive enzymes IL206364A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0759971A FR2925333B1 (fr) 2007-12-19 2007-12-19 Compositions pharmaceutiques renfermant au moins un principe actif proteinique protege des enzymes digestives
PCT/FR2008/052357 WO2009083686A1 (fr) 2007-12-19 2008-12-18 Compositions pharmaceutiques renfermant au moins un principe actif proteinique protege des enzymes digestives

Publications (2)

Publication Number Publication Date
IL206364A0 IL206364A0 (en) 2010-12-30
IL206364A true IL206364A (en) 2016-12-29

Family

ID=39671377

Family Applications (1)

Application Number Title Priority Date Filing Date
IL206364A IL206364A (en) 2007-12-19 2010-06-14 Medicinal preparations containing at least one active protein component protected by digestive enzymes

Country Status (18)

Country Link
US (1) US8309123B2 (OSRAM)
EP (1) EP2234598B1 (OSRAM)
JP (1) JP5676272B2 (OSRAM)
KR (2) KR101592609B1 (OSRAM)
CN (1) CN101917967B (OSRAM)
AP (1) AP3573A (OSRAM)
AR (1) AR069847A1 (OSRAM)
AU (1) AU2008345474B2 (OSRAM)
BR (1) BRPI0821373B8 (OSRAM)
CA (1) CA2709899C (OSRAM)
EA (1) EA023107B1 (OSRAM)
FR (1) FR2925333B1 (OSRAM)
IL (1) IL206364A (OSRAM)
MA (1) MA31927B1 (OSRAM)
MX (1) MX2010006927A (OSRAM)
TN (1) TN2010000290A1 (OSRAM)
TW (1) TWI461226B (OSRAM)
WO (1) WO2009083686A1 (OSRAM)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120035103A1 (en) * 2010-01-29 2012-02-09 Pillion Dennis J Method for administration of insulin and pharmaceutical composition thereof
US9962336B2 (en) 2014-05-01 2018-05-08 Sun Pharmaceutical Industries Limited Extended release suspension compositions
WO2016016845A1 (en) 2014-07-30 2016-02-04 Sun Pharmaceutical Industries Limited Dual-chamber pack
US10258583B2 (en) 2014-05-01 2019-04-16 Sun Pharmaceutical Industries Limited Extended release liquid compositions of guanfacine
JP2017514903A (ja) 2014-05-01 2017-06-08 サン ファーマシューティカル インダストリーズ リミテッドＳｕｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｉｎｄｕｓｔｒｉｅｓ Ｌｔｄ． 徐放性懸濁組成物
US20180104197A9 (en) 2014-05-01 2018-04-19 Sun Pharmaceutical Industries Limited Extended release liquid compositions of metformin
ES2759004T3 (es) 2014-11-04 2020-05-07 Innopharmax Inc Administración oral de medicamentos inestables o mal absorbidos
US10238803B2 (en) 2016-05-02 2019-03-26 Sun Pharmaceutical Industries Limited Drug delivery device for pharmaceutical compositions
US10369078B2 (en) 2016-05-02 2019-08-06 Sun Pharmaceutical Industries Limited Dual-chamber pack for pharmaceutical compositions
FR3120189B1 (fr) * 2021-03-01 2024-11-29 Farid Bennis Composition pharmaceutique pour une administration par voie orale d’un agoniste du récepteur du GLP-1

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE36225B1 (en) 1971-01-28 1976-09-15 Nat Res Dev Improvements relating to insulin derivatives
US4692433A (en) * 1983-10-12 1987-09-08 The Regents Of The University Of California Method and composition for regulating serum calcium levels of mammals
EP0179904A1 (en) 1984-05-09 1986-05-07 Medaphore Inc. Oral insulin and a method of making the same
US4693433A (en) * 1986-06-06 1987-09-15 Merrill David Martin Unwind stand for web rolls
US6191105B1 (en) * 1993-05-10 2001-02-20 Protein Delivery, Inc. Hydrophilic and lipophilic balanced microemulsion formulations of free-form and/or conjugation-stabilized therapeutic agents such as insulin
GB9417524D0 (en) * 1994-08-31 1994-10-19 Cortecs Ltd Pharmaceutical compositions
WO1996006632A1 (en) * 1994-09-01 1996-03-07 Allied Medical Research Associates Compositions and methods for delivery of polypeptides
US5824638A (en) * 1995-05-22 1998-10-20 Shire Laboratories, Inc. Oral insulin delivery
US5912014A (en) * 1996-03-15 1999-06-15 Unigene Laboratories, Inc. Oral salmon calcitonin pharmaceutical products
US5783556A (en) * 1996-08-13 1998-07-21 Genentech, Inc. Formulated insulin-containing composition
US6071539A (en) * 1996-09-20 2000-06-06 Ethypharm, Sa Effervescent granules and methods for their preparation
DE69738333T2 (de) * 1997-10-01 2008-11-27 Novadel Pharma Inc. Nichtpolares Spray zur bukkalen Verabreichung
SE9801495D0 (sv) * 1998-04-28 1998-04-28 Astra Ab Protein formulationa
US6531648B1 (en) * 1998-12-17 2003-03-11 Syngenta Participations Ag Grain processing method and transgenic plants useful therein
EP1031347B1 (en) * 1999-01-27 2002-04-17 Idea Ag Transnasal transport/immunisation with highly adaptable carriers
SE9904121D0 (sv) * 1999-11-15 1999-11-15 Gustaf Jederstroem Hydrophobe biomolecular structure
US6531112B2 (en) * 2000-05-15 2003-03-11 Delrx Pharmaceutical Corporation Formulations for administering calcitonin and processes for preparing the same
US7060675B2 (en) * 2001-02-15 2006-06-13 Nobex Corporation Methods of treating diabetes mellitus
US7316819B2 (en) * 2001-03-08 2008-01-08 Unigene Laboratories, Inc. Oral peptide pharmaceutical dosage form and method of production
CN1335182A (zh) * 2001-08-08 2002-02-13 华中科技大学 胰岛素口腔喷剂及其制备工艺
GB0119859D0 (en) * 2001-08-15 2001-10-10 Qinetiq Ltd Eye tracking system
US20060258561A1 (en) * 2003-03-13 2006-11-16 Novo Nordisk A/S Novel NPH insulin preparations
KR100638041B1 (ko) * 2003-12-24 2006-10-23 주식회사 삼양사 수용성 약물의 경구투여용 나노입자 조성물 및 그의제조방법
EP1765406A4 (en) * 2004-05-21 2012-11-28 Mediplex Corp ADDITIVES FOR IMPROVED MUCOSAL ABSORPTION OF THERAPEUTIC AGENTS
PT1773878E (pt) * 2004-07-19 2015-06-05 Biocon Ltd Conjugados de insulina-oligómero, formulaçôes e usos dos mesmos
EP2248531A1 (en) * 2004-08-03 2010-11-10 Emisphere Technologies, Inc. Antidiabetic oral insulin-biguanide combination
PL1883394T3 (pl) 2005-05-23 2018-09-28 Sdg, Inc. Konstrukt lipidowy do dostarczania insuliny ssakowi
US20090098205A1 (en) * 2005-09-15 2009-04-16 Council Of Scientife & Industrial Research pH SENSITIVE NANOPARTICLE FORMULATION FOR ORAL DELIVERY OF PROTEINS/PEPTIDES
WO2008048298A2 (en) * 2005-11-21 2008-04-24 Medivas, Llc Polymer particles for delivery of macromolecules and methods of use
WO2007121318A2 (en) * 2006-04-12 2007-10-25 Emisphere Technologies, Inc. Formulations for delivering insulin

Also Published As

Publication number Publication date
TW200940107A (en) 2009-10-01
MA31927B1 (fr) 2010-12-01
EA023107B1 (ru) 2016-04-29
US20090176691A1 (en) 2009-07-09
JP2011506587A (ja) 2011-03-03
AP2010005298A0 (en) 2010-06-30
JP5676272B2 (ja) 2015-02-25
MX2010006927A (es) 2010-12-06
CA2709899C (fr) 2018-01-16
KR20150132887A (ko) 2015-11-26
US8309123B2 (en) 2012-11-13
KR101592609B1 (ko) 2016-02-05
TWI461226B (zh) 2014-11-21
BRPI0821373B1 (pt) 2020-04-22
CA2709899A1 (fr) 2009-07-09
TN2010000290A1 (fr) 2011-11-11
FR2925333A1 (fr) 2009-06-26
BRPI0821373A2 (pt) 2015-06-16
CN101917967A (zh) 2010-12-15
AP3573A (en) 2016-02-08
FR2925333B1 (fr) 2012-04-13
EP2234598B1 (fr) 2025-11-19
AR069847A1 (es) 2010-02-24
AU2008345474A1 (en) 2009-07-09
KR20100095449A (ko) 2010-08-30
EA201070746A1 (ru) 2011-02-28
AU2008345474B2 (en) 2014-07-31
HK1146386A1 (en) 2011-06-03
IL206364A0 (en) 2010-12-30
WO2009083686A1 (fr) 2009-07-09
EP2234598A1 (fr) 2010-10-06
WO2009083686A9 (fr) 2009-10-15
BRPI0821373B8 (pt) 2021-05-25
CN101917967B (zh) 2013-05-22

Similar Documents

Publication Publication Date Title
IL206364A0 (en) Pharmaceutical compositions containing at least one protein active ingredient protected from digestive enzymes
EP2039366A4 (en) COMPOSITION CONTAINING PEPTIDE AS ACTIVE INGREDIENT
ZA200809002B (en) Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
IL199397A (en) Hetero-ring compounds, pharmaceuticals containing them, and their medicinal products
HUS1700016I1 (hu) Liraglutidot és degludeket tartalmazó stabil gyógyszerészeti készítmények
AP2008004671A0 (en) Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
IL199835A (en) Acid-activated antimicrobial peptides, their pharmaceutical preparations, and their use in drug preparation
PL2985026T3 (pl) Farmaceutyczne systemy dostarczania leków hydrofobowych i zawierające je kompozycje
LT3984528T (lt) Farmacinė kompozicija, apimanti nilotinibą
EP1885334A4 (en) DISCHARGE SYSTEM FOR TWO OR MORE ACTIVE SUBSTANCES AS PART OF ESTABLISHABLE COMPOSITION
ZA200900345B (en) Preparation of pharmaceutical formulations
EP2112925A4 (en) SOLID PHARMACEUTICAL DOSAGE FORMULATIONS
SI1962873T1 (sl) Farmacevtski sestavki, ki vsebujejo bakterijo za zmanjšanje oksalata
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
EP2045253A4 (en) alpha-amino acid derivative and pharmaceutical agent containing it as an active ingredient
IL195813A0 (en) Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them
IL189614A0 (en) Pharmaceutical compositions of telmisartan
IL200885A (en) A history of mannich-based compounds and pharmacological preparations including them
ZA200709788B (en) Cannabinold active pharmaceutical ingredient for Improved dosage forms
ZA200900237B (en) Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them
IL192824A (en) Peptide compounds, pharmaceuticals containing them and their use
IL186805A0 (en) Pharmaceutical compositions containing an active vitamin d compound
IL198160A0 (en) Pharmaceutical formulations
PL1744733T3 (pl) Kompozycje farmaceutyczne zamknięte w miękkich kapsułkach żelowych zawierające stężone składniki czynne
PL2046301T3 (pl) Kompozycje farmaceutyczne substancji czynnych, dla których zmiana sposobu podawania, do którego są one przeznaczone, jest trudna

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed